Windlas Biotech reported financial results for H1 FY26, achieving record revenues of Rs 432 crores and a PAT of Rs 35 crores, marking significant growth compared to last year.
AI Assistant
Windlas Biotech Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.